US FDA revokes authorization for five COVID treatments

(Reuters) - The U.S. Food and Drug Administration said on Monday it had revoked the emergency use authorization for five COVID-19 treatments, including those from Eli Lilly (NYSE:LLY ) and Regeneron (NASDAQ:REGN ).

Source: Investing.com